[HTML][HTML] Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid
neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a …
neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a …
Papillary thyroid cancer prognosis: An evolving field
S Ulisse, E Baldini, A Lauro, D Pironi, D Tripodi, E Lori… - Cancers, 2021 - mdpi.com
Simple Summary Over the last couple of decades, the prognostic stratification systems of
differentiated thyroid cancer (DTC) patients have been revised several times in an attempt to …
differentiated thyroid cancer (DTC) patients have been revised several times in an attempt to …
Deep learning fast screening approach on cytological whole slides for thyroid cancer diagnosis
Simple Summary Papillary thyroid carcinoma is the most common type of thyroid cancer and
could be cured if diagnosed and treated early. In clinical practice, the primary method for …
could be cured if diagnosed and treated early. In clinical practice, the primary method for …
High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid
Follicular-patterned tumors of the thyroid in the adult population frequently harbor RAS
mutations or PAX8-PPARG rearrangement, but little is known about molecular profiles in the …
mutations or PAX8-PPARG rearrangement, but little is known about molecular profiles in the …
Radioactive iodine therapy does not improve cancer-specific survival in Hürthle cell carcinoma of the thyroid
X Wang, X Zheng, J Zhu, Z Li… - The Journal of Clinical …, 2022 - academic.oup.com
Context It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma
M De Martino, S Pellecchia, M Decaussin-Petrucci… - Cell Cycle, 2023 - Taylor & Francis
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …
humans, and just limited progresses have been made to extend patient survival and …
Thyroid cancer detection in a routine clinical setting: performance of ACR TI-RADS, FNAC, and molecular testing in prospective cohort study
T Grimmichova, P Pacesova, M Hill, B Pekova… - Biomedicines, 2022 - mdpi.com
The aim of our study was to address the potential for improvements in thyroid cancer
detection in routine clinical settings using a clinical examination, the American College of …
detection in routine clinical settings using a clinical examination, the American College of …
Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study
Z Ding, X Tao, X Deng, B Guo, J Kang, B Wu… - Journal of Cancer …, 2023 - Springer
Purpose Locally advanced papillary thyroid cancer (LAPTC) has poor prognosis. Large-
scale genomic testing has revealed multiple oncogenic drivers which may be essential for …
scale genomic testing has revealed multiple oncogenic drivers which may be essential for …
Systematic evaluation of the anti-tumor effect of Phellinus linteus polysaccharide in thyroid carcinoma in vitro
K Yu, Z Tan, Y Xin - Molecular Biology Reports, 2022 - Springer
Background Thyroid carcinoma (TC) is the most common malignant tumor of the endocrine
system. Phellinus linteus polysaccharide (PLP) physiologically acts as a suitable anti-tumor …
system. Phellinus linteus polysaccharide (PLP) physiologically acts as a suitable anti-tumor …
Differentiating benign from malignant thyroid tumors by kinase activity profiling and dabrafenib BRAF V600E targeting
R Hilhorst, A van den Berg, P Boender, T van Wezel… - Cancers, 2023 - mdpi.com
Simple Summary Recurrent non-medullary thyroid cancer (NMTC) is difficult to treat and
therapy options are limited. Of the available compounds, serine/threonine kinase (STK) …
therapy options are limited. Of the available compounds, serine/threonine kinase (STK) …